Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Rawls

Showing results (91-100 of 133) with videos related to

Pageof 14
Sort By:
Pharmacology, Biochemistry, and Behavior|May 19, 2009
Topiramate antagonizes NMDA- and AMPA-induced seizure-like activity in planariansScott M Rawls, Timmy Thomas, Mobilaji Adeola, et al.
Pharmacology, Biochemistry, and Behavior|October 3, 2013
Opioid receptor types involved in the development of nicotine physical dependence in an invertebrate (Planaria) modelRobert B Raffa, Steve Baron, Jaspreet S Bhandal, et al.
Drug and Alcohol Dependence|May 3, 2011
Nicotine behavioral pharmacology: clues from planariansScott M Rawls, Tanvi Patil, Christopher S Tallarida, et al.
Neuropharmacology|June 24, 2025
Blocking IL-17A inhibits methamphetamine-induced hyperlocomotion and conditioned place preference and prevents methamphetamine abstinence-induced depression-like behaviors in miceSaadet Inan, Sonita Wiah, Alexandra Szmacinski, et al.
Behavioural Pharmacology|May 6, 2011
Beta-lactam antibiotic decreases acquisition of and motivation to respond for cocaine, but not sweet food, in C57Bl/6 miceSara Jane Ward, Bruce A Rasmussen, Gladys Corley, et al.
Drug and Alcohol Dependence|June 2, 2012
Mephedrone ('bath salt') elicits conditioned place preference and dopamine-sensitive motor activationRenata Lisek, Wei Xu, Ekaterina Yuvasheva, et al.
Brain Research|January 8, 2008
The kappa-opioid receptor antagonist nor-BNI inhibits cocaine and amphetamine, but not cannabinoid (WIN 52212-2), abstinence-induced withdrawal in planarians: an instance of 'pharmacologic congruence'Robert B Raffa, Gregory W Stagliano, Geoffrey Ross, et al.
British Journal of Pharmacology|September 24, 2025
Troriluzole attenuates opioid intake, reinforcing efficacy, seeking behaviours, physical dependence and antinociceptive tolerance in ratsEwa Galaj, Saadet Inan, Guo-Hua Bi, et al.
Journal of Neuroinflammation|March 2, 2021
The psychoactive drug of abuse mephedrone differentially disrupts blood-brain barrier propertiesTetyana P Buzhdygan, Cassidy R Rodrigues, Hannah M McGary, et al.
ACS Chemical Neuroscience|May 2, 2018
DARK Classics in Chemical Neuroscience: Cathinone-Derived PsychostimulantsSteven J Simmons, Jonna M Leyrer-Jackson, Chicora F Oliver, et al.
Pageof 14

Showing results (91-100 of 133) with videos related to

Sort By:
Pageof 14
Pharmacology, Biochemistry, and Behavior|May 19, 2009
Topiramate antagonizes NMDA- and AMPA-induced seizure-like activity in planariansScott M Rawls, Timmy Thomas, Mobilaji Adeola, et al.
Pharmacology, Biochemistry, and Behavior|October 3, 2013
Opioid receptor types involved in the development of nicotine physical dependence in an invertebrate (Planaria) modelRobert B Raffa, Steve Baron, Jaspreet S Bhandal, et al.
Drug and Alcohol Dependence|May 3, 2011
Nicotine behavioral pharmacology: clues from planariansScott M Rawls, Tanvi Patil, Christopher S Tallarida, et al.
Neuropharmacology|June 24, 2025
Blocking IL-17A inhibits methamphetamine-induced hyperlocomotion and conditioned place preference and prevents methamphetamine abstinence-induced depression-like behaviors in miceSaadet Inan, Sonita Wiah, Alexandra Szmacinski, et al.
Behavioural Pharmacology|May 6, 2011
Beta-lactam antibiotic decreases acquisition of and motivation to respond for cocaine, but not sweet food, in C57Bl/6 miceSara Jane Ward, Bruce A Rasmussen, Gladys Corley, et al.
Drug and Alcohol Dependence|June 2, 2012
Mephedrone ('bath salt') elicits conditioned place preference and dopamine-sensitive motor activationRenata Lisek, Wei Xu, Ekaterina Yuvasheva, et al.
Brain Research|January 8, 2008
The kappa-opioid receptor antagonist nor-BNI inhibits cocaine and amphetamine, but not cannabinoid (WIN 52212-2), abstinence-induced withdrawal in planarians: an instance of 'pharmacologic congruence'Robert B Raffa, Gregory W Stagliano, Geoffrey Ross, et al.
British Journal of Pharmacology|September 24, 2025
Troriluzole attenuates opioid intake, reinforcing efficacy, seeking behaviours, physical dependence and antinociceptive tolerance in ratsEwa Galaj, Saadet Inan, Guo-Hua Bi, et al.
Journal of Neuroinflammation|March 2, 2021
The psychoactive drug of abuse mephedrone differentially disrupts blood-brain barrier propertiesTetyana P Buzhdygan, Cassidy R Rodrigues, Hannah M McGary, et al.
ACS Chemical Neuroscience|May 2, 2018
DARK Classics in Chemical Neuroscience: Cathinone-Derived PsychostimulantsSteven J Simmons, Jonna M Leyrer-Jackson, Chicora F Oliver, et al.
Pageof 14